The sequential paradigm of data acquisition and analysis in next-generation sequencing 9 leads to high turnaround times for the generation of interpretable results. We designed a 10 workflow using an advanced real-time read mapping approach to obtain reliable variant calls 11 for human whole-exome data still during the sequencing process. When compared to 12 standard routines, our live variant calling approach enables considerably faster interventions 13 in clinical applications such as pathogen characterization and the determination of drug 14 resistances in disease outbreaks or the design of individually tailored vaccines in precision 15 medicine. Besides variant calling, our approach can be adapted for a plethora of other 16 mapping-based analyses. 17
Background 21
Common workflows for the analysis of next-generation sequencing (NGS) data can only be 22 applied after sequencing has finished. In time-critical applications, however, this sequential 23 paradigm of data acquisition and analysis is one of the main bottlenecks leading to high 24 turnaround times. Examples for such time-critical analyses range from the production of 25 individually tailored vaccines for cancer immunotherapy [2] , to the determination of M. 26 tuberculosis drug resistances [3] , and to the identification of pathogens, virulence factors, 27 drug resistances and paths of disease transmission in infectious disease outbreaks [4, 5] . 28
While having considerably higher turnaround times than alternative approaches such as 29 molecular tests, NGS provides a more open view as well as more extensive and reliable 30 results. During bioinformatics analysis of NGS data, variant calling is a crucial step to find 31 differences in the genomic sequence of the investigated sample when compared to a 32 reference genome. Thereby, valuable information for the treatment of a patient can be 33 obtained such as strain level classification and drug resistances of a pathogen or individual 34 characteristics of healthy and defected tissue. To reduce the turnaround time for the 35 generation of NGS-based results and to enable fast and accurate treatment of patients, we 36 designed a workflow to obtain variant calling results before sequencing has finished. The 37 workflow is based on real-time read mapping results with HiLive2 followed by fast and 38 accurate variant calling with xAtlas. In doing so, live results can be obtained several hours 39 before all data are written by the sequencer and provide increasing insights into the sample 40 over sequencing time. 41
Methods

42
In this chapter, we provide a description of our workflow and the methods for evaluation. 43
More detailed information for each step such as direct links to the data and the executed 44 commands can be found in the supplementary material. All software versions used in this 45 study are listed in the Software versions section (Table 1) . 46
Implementation of HiLive2 47
HiLive2 is based on a novel algorithm using the efficient FM-index implementation of the 48 SeqAn library [6] . Each alignment starts with a short exact match sequence of length k, 49 referred to as seed k-mer. The length of this k-mer is set according to the size of the 50 reference genome and the read length or can be manually specified by the user. Starting from the seed k-mer, the alignment is extended in the sequencing direction of the read. Apart 52 from a front soft clip that occurs due to k-mer mismatches at the beginning of a read, the 53 algorithm guarantees to produce optimal mapping results for non-affine gap costs. HiLive2 is 54 an all-mapper by design meaning that all alignments up to a specified score can be found. 55
However, the default output option of HiLive2 is to return only one best alignment for each 56 read which is the expected behavior for most analyses. During output, temporary files are 57 stored for all output cycles such that new output with the same or different output options can 58 be created by a separate executable. Output is created in the well-established BAM or SAM 59 format. 60
Data download and conversion 61
The human reference genome hg19 was obtained from NCBI and only considered 62 chromosomes 1-22, X and Y. Alternative regions were omitted. The sequences were stored 63 in a single multi-FASTA file. For the evaluation of variant calls with RTG Tools [7], the 64 reference genome was converted to SDF format. 65
Seven whole-exome sequencing (WES) data sets of the human individual NA12878 were 66 downloaded from EBI in FASTQ format. For read mapping with HiLive2, read pairs were 67 converted to Illumina base call file format (BCL), distributed on one lane and 64 tiles. There 68 were four different definitions for exome capture region definition required for the different 69 data sets (cf. Table 2 ). The regions were obtained in BED format from the respective 70 producer, if available. Whenever multiple definition files were provided, the primary target 71 regions were selected. 72
Gold standard variants for the individual NA12878 were downloaded from the Genome in a 73 Bottle (GIAB) consortium [8] and regularized with the vcfallelicprimitives tool of VCFtools [9] . 74 SNPs and indels of the gold standard were stored in two separated files and filtered out 75 against the exome capture regions using Bedtools [10] intersect. The resulting files were 76 used as the gold standard for data sets using the respective exome capture definition. During the evaluation of the results, only variant calls in high confidence homozygous regions which 78 were obtained from GIAB were considered. 79
Real-time read mapping with HiLive2 80
The index of human reference genome hg19 for HiLive2 was built with default parameters. 81
The creation of base call files by the sequencing machine was simulated using a script for 82 sequencing simulation with a sequencing profile for HiSeq2500 machines in rapid mode and 83 using dual barcodes. As no barcodes were present in our data sets, no data was written by 84 the sequencing simulator for the respective cycles. HiLive2 was run in fast mode allowing 85 faster turnaround times at the expense of slightly lower recall. Technical parameters as 86 lanes, tiles and read length were set for each run according to the respective data sets. In 87 general, we chose cycles 30, 40, 55, 75 and 100 for each of the two reads as output cycles. 88
For data sets with read lengths other than 2 x 100bp, we adapted the output cycle numbers 89 to 30, 40 and 50 (SRR292250) or 30, 40, 55 and 76 (SRR098401). We used the 90 recommended number of threads (1 thread per tile) for HiLive2 resulting in 64 threads for all 91 data sets. 92
Read mapping with Bowtie 2 93
The index of the human reference genome hg19 for Bowtie 2 was built with default 94 parameters. Read mapping with Bowtie 2 was performed with default parameters using 10 95 threads. 96
Variant calling with xAtlas 97
Variant calling with xAtlas was performed for each chromosome individually. Therefore, the 98 alignment files of HiLive2 or Bowtie 2 were split in 24 files (one for each chromosome). The 99 resulting files were sorted and indexed using samtools [11] . Afterwards, variants were called 100 with xAtlas for the respective exome capture regions using default parameters. Sorting, 101 indexing and variant calling was performed with 24 threads (one thread per chromosome). 102
The resulting VCF files were merged using VCFLIB vcf-concat [12] for SNVs and indels 103 separately. 104
Measure of turnaround time 105
The sequencing simulation script provides timestamps for each written sequencing cycle. 106
These timestamps were compared to the system time stamps for the last modification of the 107 alignment output files of HiLive2. The time span between both time stamps describes the 108 alignment delay of HiLive2. Additionally, we measured the clock time of the xAtlas pipeline. 109
The sum of sequencing time until the respective cycle, the alignment delay of HiLive2 and 110 the clock time of xAtlas yields the overall turnaround times of our workflow. 111
Evaluation with RTG Tools 112
We used the vcfeval program of RTG Tools for the validation of variant calling results. We 113 used the gold standard for the respective data set (depending on the used exome kit) as 114 baseline and the variant calling output of xAtlas or GATK as call. The human reference hg19 115 in SDF format was used as reference template. Only variant calls being included in the high-116
confidence regions for individual NA12878 provided by the GIAB consortium were 117 considered for validation. We ran RTG Tools with 24 threads and used the squash-ploidy 118 and all-records parameters. For variant calls produced by xAtlas, we additionally defined 119 QUAL as the field for variant call quality. For GATK, the GQ field is chosen by default. RTG 120 Tools vcfeval returns a list of statistical measures for different thresholds of the variant call 121 quality field, including precision and recall. These values served as input for the precision-122 recall curves shown in Supplementary Fig. 1 and used for the calculation of the area under 123 the precision-recall curves (APR). 124
Software versions 125
All analyses performed in this study were done with the software versions listed in Table 1 . Genome in a Bottle (GIAB) consortium [8] . As benchmarking method we used the area under 153 the precision-recall curve (APR). 154
Accuracy of real-time results 155
In Illumina sequencing, all reads are sequenced in parallel. In each so-called sequencing 156 cycle, sequence information of one additional nucleotide is obtained for all reads. Thus, the 157 current length of a read equals the number of the respective cycle (e.g., 40 nucleotides after 158 cycle 40). To demonstrate the capability of our approach to provide interpretable results 159 during runtime, we applied our workflow at different stages of sequencing. We expected our 160 live results to show higher accuracy for higher cycles due to the increasing amount of 161 available sequence information. At the same time, we analyzed whether the detected 162 variants in early sequencing cycles are as reliable as variants called at the end of 163 sequencing. This is a crucial criterion for our real-time workflow since interpretation of live 164 results is only meaningful when based on reliable variant calls. Therefore, besides comparing 165 1 M≔ millions the APR values of different sequencing cycles, we also examined precision and recall 166 separately. Fig. 1a shows the progression of the APR values for SNP calling in all analyzed 167 data sets with increasing sequencing time. In cycle 30, sequence information was not 168 sufficient to call any variants with the given parameter settings for six of seven data sets. For 169 data set SRR292250, read mapping parameters were adapted by HiLive2 automatically due 170 to the short read length of 50bp. This led to earlier results after 30 cycles while first results 171 were available after cycle 40 for all other data sets. Results show a continuous increase of 172 the APR values for all cycles of the first read. In cycle 75, an APR larger than 0.9 was 173 achieved for all data sets with sufficient read length. Afterwards, the APR values continue 174 available until the end of the first read. The progression of all curves is similar to that of the APR curve (cf. Fig.   1a ), indicating the correlation between those two measures. *Cycle 50 for SRR292250, cycle 55 for all other data sets. **Cycle 76 for SRR098401, cycle 75 for all other data sets. increasing moderately. When regarding the progression of precision (Fig. 1b) and recall (Fig.  175 1c) over sequencing time separately, it can also be also observed that lower APR values for 176 earlier sequencing cycles are mainly caused by a lower recall while precision changes only 177 slightly with more sequence information. The same conclusions are supported by the 178 individual precision-recall curves for all data sets which show a large increase of the recall 179 but only minor changes of specificity over sequencing time (cf. Supplementary Fig. 1 ). This 180 indicates that live results are highly reliable and can therefore serve for early interpretation 181 and problem-specific follow-up analyses. The increasing number of SNP calls in subsequent 182 cycles provides additional information for complementing the previous interpretation of the 183 data. However, the final results with HiLive2 show slightly lower maximum recall values than 184 the same workflow applied to read mapping results of Bowtie 2 (cf. Supplementary Fig. 1) . 185
This can be explained by the read mapping approach of HiLive2 which tolerates only a 186 specified number of errors for a read. Thus, regions with a high number of variations may be 187 lowly covered which leads to undetected variants. The same effect is somewhat stronger for 188 indels as the algorithm only tolerates indels with a maximum length of three nucleotides by 189 default. While this behavior led to a lower recall than based on read mapping with Bowtie 2, 190 the results showed comparable or higher precision (cf. Supplementary Fig. 1) . Thus, 191 although focussing on SNPs in this study, our workflow can also provide valuable insights 192 about small indels. 193
Turnaround time of the workflow 194
Besides the accuracy of results, turnaround time is the second crucial factor for NGS-based 195 real-time analyses. Thereby, live results should be available as soon as possible after the 196 data of the respective sequencing cycle was written without showing significant delay in any 197 stage of sequencing. 198
We measured the turnaround time of real-time mapping with HiLive2 and subsequent variant 199 calling with xAtlas for the same runs that delivered the accuracy results shown before. All 200 computations were run on a 128-core machine (Intel® Xeon® CPU E5-4667 v4 @ 201 2.20 GHz, 45 M Cache) with 500GB RAM, using a maximum of 65 threads per data set. 202 Fig. 2 shows an overview for the turnaround time of our workflow for different sequencing 203 cycles for data set SRR1611178. On average, variant calling results were available less than 204 half an hour after the data were written by the sequencing machine. The results for cycle 40 205 were written after 294 minutes, showing that first reliable and interpretable variant calls were 206 available less than five hours after sequencing started. For higher coverage data sets, such 207 as data set SRR515199, the alignment delay of HiLive2 and runtime of xAtlas increase when 208 performed with the same number of threads (cf. Supplementary Fig. 2 ). However, five of the 209 seven data sets in this study showed a maximum time span of less than one hour from data 210 output to interpretable results for each sequencing cycle. The turnaround times for all data 211 sets are shown in Supplementary Fig. 2 . 212 
Discussion
213
Our results show that real-time read mapping results in very early stages of sequencing can 214 already serve as input for variant calling and deliver confident results. However, the quantity 215 of analysis results (i.e. the number of called variants in this study) increases with a growing 216 number of sequenced nucleotides per read. Live analyses can therefore provide first relevant 217 insights into the data while the analysis becomes more comprehensive with ongoing 218 sequencing. Thereby, our approach does not only apply to the presented use case of variant 219 calling. We rather see the enormous potential of real-time read mapping to provide means for 220 a wide range of complex follow-up analyses. 221
In clinical applications and infectious disease outbreaks, the turnaround time of analyses is a 222 critical factor for an effective treatment of patients. However, a high depth of analysis and an 223 open perspective for unexpected findings are further crucial criteria in such scenarios. 224
Despite its significantly higher turnaround times than alternative methods, NGS presents an 225 established analysis method in several time-critical applications due to its high sensitivity. [19] . To further accelerate such analyses, we showed that live 231 results can deliver a major proportion of the full analysis depth already in a fraction of the 232 final sequencing time. These results demonstrate the enormous potential of our approach to 233 reduce the turnaround time from sample arrival to meaningful analysis output by several 234 hours. However, alternative approaches can also be highly valuable for different scenarios. 235
Molecular approaches are usually highly reliable and provide answers to specific questions in 236 a very short timeframe and at much lower costs. For example, the detection of 25 genetic 237 mutations in M. tuberculosis that confer to drug resistances can be finished in approximately 238 two hours with a variation of the molecular GeneXpert test [3] . Even when providing live results, such short turnaround times are currently not feasible with NGS-based approaches 240 due to the required time for sample preparation. However, NGS enables more detailed and 241 unbiased analyses ranging from strain level identification to the determination of infection 242 chains. Another interesting technology for time-critical applications is nanopore sequencing. 243
It was shown that metagenomic detection of viral pathogens can be achieved in less than six 244 hours [20] . While nanopore sequencing shows a high portability as an additional benefit, this 245 and other current long-read technologies are still expensive and limited by their 246 comparatively low coverage and high error rates. It is therefore hard to reliably identify lowly 247 abundant pathogens, genetic variants, parallel infections or the presence of viral 248 quasispecies. Thus, especially when it comes to these or other questions going beyond the 249 identification of highly abundant pathogens in time-critical applications, real-time analyses for 250
Illumina sequencing can be of great benefit. 251
Conclusion
252
We consider our new real-time workflow for NGS to be a complementary method to 253 molecular tests and ultra-portable, long-read sequencing for time-critical analyses. It fills the 254 current gap of short turnaround times, an open-view perspective and high sequencing 255 coverage which is essential for a plethora of applications such as pathogen identification and 256 characterization, personalized vaccine design or epidemiological analyses. Therefore, we are 257 convinced that our approach will improve the ability for fast interventions in exceptional 258 clinical situations, personalized medicine and infectious disease outbreaks. 259 
